vs

Side-by-side financial comparison of INVO Fertility, Inc. (IVF) and Serve Robotics Inc. (SERV). Click either name above to swap in a different company.

INVO Fertility, Inc. is the larger business by last-quarter revenue ($1.8M vs $881.5K, roughly 2.0× Serve Robotics Inc.). INVO Fertility, Inc. runs the higher net margin — -150.5% vs -3888.1%, a 3737.6% gap on every dollar of revenue. On growth, Serve Robotics Inc. posted the faster year-over-year revenue change (400.1% vs 22.6%). INVO Fertility, Inc. produced more free cash flow last quarter ($-1.8M vs $-46.1M). Over the past eight quarters, INVO Fertility, Inc.'s revenue compounded faster (12.8% CAGR vs -3.5%).

INVO Fertility, Inc. is a specialized healthcare company focused on delivering accessible assisted reproductive technology solutions. It develops, manufactures and markets the patented INVOcell intravaginal culture system for in vitro fertilization procedures, serving fertility clinics and patients across North America, Europe and other global regions, with a mission to reduce barriers to high-quality fertility care.

Ecovacs Robotics is a Chinese technology company. It is best known for developing in-home robotic appliances. The company was founded in 1998 by Qian Dongqi and is headquartered in Suzhou, China. According to Global Asia, Ecovacs Robotics had more than 60% of the Chinese market for robots by 2013. In 2023, Nikkei Asia had reported that the market capitalisation of Ecovacs Robotics has grown to near $6.38 billion, which is "roughly 5 times" that of the market capitalisation of rivalling US bas...

IVF vs SERV — Head-to-Head

Bigger by revenue
IVF
IVF
2.0× larger
IVF
$1.8M
$881.5K
SERV
Growing faster (revenue YoY)
SERV
SERV
+377.4% gap
SERV
400.1%
22.6%
IVF
Higher net margin
IVF
IVF
3737.6% more per $
IVF
-150.5%
-3888.1%
SERV
More free cash flow
IVF
IVF
$44.4M more FCF
IVF
$-1.8M
$-46.1M
SERV
Faster 2-yr revenue CAGR
IVF
IVF
Annualised
IVF
12.8%
-3.5%
SERV

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
IVF
IVF
SERV
SERV
Revenue
$1.8M
$881.5K
Net Profit
$-2.6M
$-34.3M
Gross Margin
-757.3%
Operating Margin
-93.1%
-4572.1%
Net Margin
-150.5%
-3888.1%
Revenue YoY
22.6%
400.1%
Net Profit YoY
-62.2%
-161.3%
EPS (diluted)
$-0.77
$-0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IVF
IVF
SERV
SERV
Q4 25
$881.5K
Q3 25
$1.8M
$687.0K
Q2 25
$1.9M
$642.0K
Q1 25
$1.6M
$440.5K
Q4 24
$1.7M
$176.3K
Q3 24
$1.4M
$222.0K
Q2 24
$1.8M
$468.0K
Q1 24
$1.6M
$946.7K
Net Profit
IVF
IVF
SERV
SERV
Q4 25
$-34.3M
Q3 25
$-2.6M
$-33.0M
Q2 25
$-5.3M
$-20.9M
Q1 25
$-17.4M
$-13.2M
Q4 24
$-3.6M
$-13.1M
Q3 24
$-1.6M
$-8.0M
Q2 24
$-2.2M
$-9.0M
Q1 24
$-1.6M
$-9.0M
Gross Margin
IVF
IVF
SERV
SERV
Q4 25
-757.3%
Q3 25
-637.4%
Q2 25
-445.3%
Q1 25
35.2%
-333.4%
Q4 24
41.4%
-371.7%
Q3 24
31.0%
-70.3%
Q2 24
53.1%
30.3%
Q1 24
45.3%
62.8%
Operating Margin
IVF
IVF
SERV
SERV
Q4 25
-4572.1%
Q3 25
-93.1%
-5067.8%
Q2 25
-160.4%
-3527.1%
Q1 25
-1042.1%
-3406.6%
Q4 24
-202.0%
-7701.3%
Q3 24
-90.7%
-3804.1%
Q2 24
-100.9%
-1828.2%
Q1 24
-95.7%
-814.6%
Net Margin
IVF
IVF
SERV
SERV
Q4 25
-3888.1%
Q3 25
-150.5%
-4806.4%
Q2 25
-283.6%
-3247.7%
Q1 25
-1060.1%
-3000.5%
Q4 24
-211.3%
-7441.8%
Q3 24
-113.8%
-3601.8%
Q2 24
-122.2%
-1931.2%
Q1 24
-101.3%
-954.7%
EPS (diluted)
IVF
IVF
SERV
SERV
Q4 25
$-0.50
Q3 25
$-0.77
$-0.54
Q2 25
$-13.30
$-0.36
Q1 25
$-12.53
$-0.23
Q4 24
$14.86
$-0.23
Q3 24
$-15.11
$-0.20
Q2 24
$-22.39
$-0.27
Q1 24
$-7.55
$-0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IVF
IVF
SERV
SERV
Cash + ST InvestmentsLiquidity on hand
$106.2M
Total DebtLower is stronger
$2.0M
Stockholders' EquityBook value
$5.8M
$350.7M
Total Assets
$18.8M
$367.8M
Debt / EquityLower = less leverage
0.34×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IVF
IVF
SERV
SERV
Q4 25
$106.2M
Q3 25
$116.8M
Q2 25
$116.7M
Q1 25
$197.8M
Q4 24
$123.3M
Q3 24
$50.9M
Q2 24
$28.8M
Q1 24
Total Debt
IVF
IVF
SERV
SERV
Q4 25
Q3 25
$2.0M
Q2 25
$4.8M
Q1 25
Q4 24
$7.5M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
IVF
IVF
SERV
SERV
Q4 25
$350.7M
Q3 25
$5.8M
$283.9M
Q2 25
$2.6M
$207.2M
Q1 25
$3.3M
$210.2M
Q4 24
$12.7M
$131.7M
Q3 24
$-23.3K
$56.2M
Q2 24
$1.4M
$28.5M
Q1 24
$10.2K
$-8.8M
Total Assets
IVF
IVF
SERV
SERV
Q4 25
$367.8M
Q3 25
$18.8M
$299.1M
Q2 25
$19.3M
$214.3M
Q1 25
$31.7M
$216.6M
Q4 24
$46.4M
$139.6M
Q3 24
$17.0M
$61.5M
Q2 24
$17.8M
$32.8M
Q1 24
$17.3M
$4.2M
Debt / Equity
IVF
IVF
SERV
SERV
Q4 25
Q3 25
0.34×
Q2 25
1.83×
Q1 25
Q4 24
0.59×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IVF
IVF
SERV
SERV
Operating Cash FlowLast quarter
$-1.8M
$-29.6M
Free Cash FlowOCF − Capex
$-1.8M
$-46.1M
FCF MarginFCF / Revenue
-101.6%
-5234.4%
Capex IntensityCapex / Revenue
0.5%
1872.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-7.8M
$-117.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IVF
IVF
SERV
SERV
Q4 25
$-29.6M
Q3 25
$-1.8M
$-25.2M
Q2 25
$-1.7M
$-16.0M
Q1 25
$-3.5M
$-9.5M
Q4 24
$-617.4K
$-6.3M
Q3 24
$-640.8K
$-5.5M
Q2 24
$-1.5M
$-5.7M
Q1 24
$-260.6K
$-4.1M
Free Cash Flow
IVF
IVF
SERV
SERV
Q4 25
$-46.1M
Q3 25
$-1.8M
$-36.5M
Q2 25
$-1.7M
$-22.0M
Q1 25
$-3.6M
$-12.9M
Q4 24
$-696.3K
$-11.1M
Q3 24
$-10.1M
Q2 24
$-1.5M
$-6.5M
Q1 24
$-310.3K
$-4.1M
FCF Margin
IVF
IVF
SERV
SERV
Q4 25
-5234.4%
Q3 25
-101.6%
-5314.1%
Q2 25
-92.6%
-3426.8%
Q1 25
-216.9%
-2934.1%
Q4 24
-40.6%
-6307.8%
Q3 24
-4529.7%
Q2 24
-82.3%
-1396.6%
Q1 24
-19.7%
-431.1%
Capex Intensity
IVF
IVF
SERV
SERV
Q4 25
1872.1%
Q3 25
0.5%
1649.6%
Q2 25
0.5%
940.4%
Q1 25
0.9%
785.7%
Q4 24
4.6%
2755.1%
Q3 24
0.0%
2070.7%
Q2 24
3.0%
169.8%
Q1 24
3.2%
0.4%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons